Overall well-being encompasses more than physical appearance and fitness. Addressing the mind is an essential part of achieving balance and confidence. The breakthrough EXOMIND TM therapy is designed to treat symptoms of depression, helping patients regain control and improve their quality of life.
Used for the treatment of depression, Exomind’s patented ExoTMS TM technology comfortably stimulates key areas of the brain involved in emotional regulation, cognitive function, and self-control. By activating neural pathways, it helps restore healthy brain activity and enhances neural connectivity for mental wellness.
Frequently Asked Questions
01
What is EXOMIND therapy?
EXOMIND is a ground-breaking mental wellness therapy that marks a new era in patient care. It is a noninvasive, drug-free walk-in walk-out procedure designed to treat symptoms of depression, helping patients regain control and improve their quality of life.
03
What are the benefits of EXOMIND?
rTMS is a noninvasive treatment and is free from common antidepressant drug side effects such as weight gain and sexual dysfunction.
05
How many sessions are required?
A course of rTMS traditionally requires multiple treatments. Patients should discuss the number of treatments and treatment schedule with their physicians. rTMS treatment effects in reducing depression are temporary, and patients may need to continue other forms of depression therapy. Relapse into depression is likely without follow-up treatment.
07
Does it hurt?
Most patients find the therapy comfortable. Sessions are quick, lasting under 30 minutes, and allow you to walk in and walk out with ease.
09
What are the risks?
Therapy by rTMS is generally well tolerated. Nevertheless it may, for some, cause headache, scalp pain, seizure and hypomania. As with any medical procedure, there are some risks associated with EXOMIND therapy. Please discuss risks and contraindications with your healthcare practitioner before beginning treatment.
11
How long will the results last?
Although the durability of rTMS therapy in the treatment of depression has been suggested in several clinical reports for up to 12 months, MDD patients need to be monitored post treatment and may need to continue or resume antidepressant medications.
02
How does it work?
FDA-cleared for the treatment of depression†, EXOMIND's patented ExoTMS™ technology comfortably stimulates key areas
of the brain involved in emotional regulation, cognitive function, and self-control. By activating neural pathways, it helps restore healthy brain activity and enhances neural connectivity.
04
Is EXOMIND right for me?
EXOMIND is designed for individuals experiencing depression. Consult with your healthcare provider to determine if EXOMIND is the right option for your mental wellness journey.
06
What does the therapy feel like?
During EXOMIND therapy, you will lie down comfortably while the applicator is placed on your head. As the treatment begins, you may feel a tapping or tingling sensation in the treated area, often described by patients as similar to a head massage. After the session, you can resume normal activities immediately. In some cases, a slight headache may occur in the treated area, but it typically subsides within minutes.
08
Will it disrupt my daily life?
EXOMIND seamlessly integrates into your daily routine with minimal disruption.
10
What to do if the patient experiences discomfort during the therapy?
If the patient experiences discomfort, such as finger twitching, pause the therapy and move the applicator anteriorly or posteriorly in 0.2 in (0.5 cm) increments, up to a maximum of 0.6 in (1.5 cm) from the starting position. If repositioning the coil does not alleviate the discomfort, consider decreasing the therapy intensity.
12
Are there any alternative treatments?
Alternative treatments such as medications, psychotherapy, and electroconvulsive therapy are available. Consult with your physician what best fits your condition.
Patient results and experience may vary. BTL devices should only be used under the continued supervision of a physician or licensed practitioner. Refer to the owner's manual for the full list of contraindications, side effects, and precautions. †EXOMIND is intended to be used for the treatment of Major Depressive Disorder (MDD) in adult patients who have failed to achieve satisfactory improvement from prior antidepressant medication in the current episode. BTL ®, EMSCULPT NEO®, NEO™, EMSCULPT®, EMSELLA®, EXILIS®, EMTONE®, HIFEM®, HIFES®, EMFEMME 360®, Core to floor®, EXION®, EMFACE®, ExoTMS™ and EXOMIND™ are trademarks and/or registered trademarks in the United States of America, the European Union, and other countries. The products, the methods of manufacture or their use may be protected by one or more U.S. or foreign patents or pending applications, see www.btlnet.com/patents. Trademarks EMSCULPT, EMSCULPT NEO, EMSELLA, EMTONE, EMFEMME 360, EMFACE and EMBODY are associated with the EM® family of products and services.